{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:38Z","timestamp":1786649918447,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The prevalence of papillary thyroid cancer (PTC) is increasing in India and other high-income countries. A high prevalence of thyroid cancer has been reported in Kerala\u2014a state in southern India. A significant conclusion is that Thiruvananthapuram, the capital of Kerala, ranks first among males and second among women in terms of the incidence of TC in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The objective of this study was to investigate the clinical significance of TERT Promoter mutations in thyroid carcinoma. Specifically, this study aimed to determine the prevalence of TERT promoter mutations in a cohort of patients with thyroid carcinoma and analyze the association between TERT Promoter mutations and clinicopathological characteristics of thyroid carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this study, patients with PTC were enrolled between 2020 and 2021. Mutation analysis of TERT gene promoter was successfully performed in 47 patients using the PCR amplification of TERT promoter region followed by direct sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>PTC harboring TERT Promoter mutation was detected in 18 out of 47 patients (38%). The presence of TERT promoter mutations and various clinicopathological characteristics were compared. Statistical analysis reveals that the clinicopathological parameters, such as clinical as well as pathological stage of disease have significant association with the TERT promoter mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These findings highlight the potential of TERT promoter mutations as valuable prognostic indicators and suggest their potential utility as therapeutic targets in PTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_460_24","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T15:57:43Z","timestamp":1743695863000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Frequency of TERT promoter mutation and its association with clinicopathologic factors in papillary thyroid carcinoma in Kerala population"],"prefix":"10.4103","volume":"21","author":[{"given":"Dhanya","family":"Krishnan","sequence":"first","affiliation":[{"name":"Division of Cancer Research, Regional Cancer Centre (Research Centre: University of Kerala), Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Suresh","sequence":"additional","affiliation":[{"name":"Division of Sugical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebu A.","family":"George","sequence":"additional","affiliation":[{"name":"Division of Sugical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Anila","sequence":"additional","affiliation":[{"name":"Division of Pathology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kannan","sequence":"additional","affiliation":[{"name":"Division of Cancer Research, Regional Cancer Centre (Research Centre: University of Kerala), Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"R1-20250403","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250403","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3332\/ecancer.2023.1546","article-title":"Proportion of papillary thyroid microcarcinoma in Kerala, India, over a decade:A retrospective cohort study","volume":"17","author":"Benny","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"R3-20250403","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1210\/js.2017-00097","article-title":"Rising thyroid cancer incidence in southern India:An epidemic of overdiagnosis?","volume":"1","author":"Mathew","year":"2017","journal-title":"J Endocr Soc"},{"key":"R4-20250403","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/ijph.ijph_1419_22","article-title":"Spatiotemporal pattern of thyroid cancer incidence in South Kerala:A population-based study","volume":"67","author":"George","year":"2023","journal-title":"Indian J Public Health"},{"key":"R5-20250403","first-page":"35","article-title":"Spatial distribution of cancer in Trivandrum, India using geographic information system:Pilot study","volume":"9","author":"George","year":"2016","journal-title":"Acad J Cancer Res"},{"key":"R6-20250403","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12020-019-02117-2","article-title":"Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma:A systematic review and meta-analysis","volume":"67","author":"Yang","year":"2020","journal-title":"Endocrine"},{"key":"R7-20250403","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41467-018-03033-1","article-title":"Regulation of mutant TERT by BRAF V600E\/MAP kinase pathway through FOS\/GABP in human cancer","volume":"9","author":"Liu","year":"2018","journal-title":"Nat Commun"},{"key":"R8-20250403","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol"},{"key":"R9-20250403","doi-asserted-by":"crossref","first-page":"643151","DOI":"10.3389\/fendo.2021.643151","article-title":"Advances in detecting low prevalence somatic TERT promoter mutations in papillary thyroid carcinoma","volume":"12","author":"Da","year":"2021","journal-title":"Front Endocrinol"},{"key":"R10-20250403","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1007\/s13277-015-4694-2","article-title":"TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas","volume":"37","author":"Vinothkumar","year":"2016","journal-title":"Tumor Biol"},{"key":"R11-20250403","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R12-20250403","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SLA.0b013e318148563d","article-title":"The prevalence and prognostic value of BRAF mutation in thyroid cancer","volume":"246","author":"Kebebew","year":"2007","journal-title":"Ann Surg"},{"key":"R13-20250403","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1210\/clinem\/dgaa192","article-title":"Thyroid cancer incidence in india between 2006 and 2014 and impact of overdiagnosis","volume":"105","author":"Panato","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20250403","year":"2022","journal-title":"Regional Cancer Centre, Thiruvananthapuram, Kerala, India. Annual Report 2021-22"},{"key":"R15-20250403","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol"},{"key":"R16-20250403","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide:GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R17-20250403","first-page":"1045","article-title":"Classification and general considerations of thyroid cancer","volume":"3","author":"Katoh","year":"2015","journal-title":"Ann Clin Pathol"},{"key":"R19-20250403","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol Cancer"},{"key":"R20-20250403","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.21037\/atm-20-5024","article-title":"Telomerase reverse transcriptase promoter mutations in thyroid carcinomas:Implications in precision oncology\u2014A narrative review","volume":"8","author":"Yuan","year":"2020","journal-title":"Ann Transl Med"},{"key":"R21-20250403","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/oncolo\/oyad208","article-title":"TERT promoter mutations frequency across race, sex, and cancer type","volume":"29","author":"Zarif","year":"2024","journal-title":"Oncologist"},{"key":"R22-20250403","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/cancers15020413","article-title":"Effect of having concurrent mutations on the degree of aggressiveness in patients with thyroid cancer positive for TERT promoter mutations","volume":"15","author":"Alohali","year":"2023","journal-title":"Cancers"},{"key":"R23-20250403","doi-asserted-by":"crossref","first-page":"592202","DOI":"10.3389\/fonc.2020.592202","article-title":"Perspectives on the treatment of advanced thyroid cancer:Approved therapies, resistance mechanisms, and future directions","volume":"10","author":"Porter","year":"2021","journal-title":"Front Oncol"},{"key":"R24-20250403","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"R25-20250403","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3390\/jcm10102179","article-title":"Prospective analysis of TERT promoter mutations in papillary thyroid carcinoma at a single institution","volume":"10","author":"Choi","year":"2021","journal-title":"J Clin Med"},{"key":"R26-20250403","doi-asserted-by":"crossref","first-page":"e0153319","DOI":"10.1371\/journal.pone.0153319","article-title":"BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patients","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"R27-20250403","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/cancers13040648","article-title":"TERT promoter mutations and the 8th edition TNM classification in predicting the survival of thyroid cancer patients","volume":"13","author":"Park","year":"2021","journal-title":"Cancers"},{"key":"R28-20250403","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cen.12999","article-title":"TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas","volume":"85","author":"Bullock","year":"2016","journal-title":"Clin Endocrinol"},{"key":"R29-20250403","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20250403","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/ERC-16-0219","article-title":"TERT promoter mutations and long-term survival in patients with thyroid cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"R31-20250403","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1038\/srep36990","article-title":"TERT promoter mutation and its association with clinicopathological features and prognosis of papillary thyroid cancer:A meta-analysis","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"R32-20250403","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.3390\/cancers14194928","article-title":"TERT Promoter and BRAF V600E mutations in papillary thyroid cancer:A single-institution experience in Korea","volume":"14","author":"Kim","year":"2022","journal-title":"Cancers"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_460_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:52Z","timestamp":1786647592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_460_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_460_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}